Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Ekins

Showing results (91-100 of 374) with videos related to

Pageof 38
Sort By:
Journal of Cheminformatics|March 24, 2015
Machines first, humans second: on the importance of algorithmic interpretation of open chemistry dataAlex M Clark, Antony J Williams, Sean Ekins
Drug Discovery Today|July 23, 2023
Learning from COVID-19: How drug hunters can prepare for the next pandemicAna C Puhl, Thomas R Lane, Sean Ekins
Nature Machine Intelligence|October 10, 2022
Dual Use of Artificial Intelligence-powered Drug DiscoveryFabio Urbina, Filippa Lentzos, Cédric Invernizzi, et al.
Trends in Pharmacological Sciences|April 23, 2003
In vitro and pharmacophore insights into CYP3A enzymesSean Ekins, David M Stresser, J Andrew Williams
Plos Neglected Tropical Diseases|October 21, 2016
OpenZika: An IBM World Community Grid Project to Accelerate Zika Virus Drug DiscoverySean Ekins, Alexander L Perryman, Carolina Horta Andrade
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2015
Making Transporter Models for Drug-Drug Interaction Prediction MobileSean Ekins, Alex M Clark, Stephen H Wright
Journal of Proteome Research|July 25, 2008
Intrinsic disorder in nuclear hormone receptorsMatthew D Krasowski, Erica J Reschly, Sean Ekins
Pharmaceutical Research|November 6, 2020
Correction to: Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyondSean Ekins, Thomas R Lane, Peter B Madrid
F1000Research|July 18, 2014
Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal NeuropathyLori Sames, Allison Moore, Renee Arnold, et al.
GEN Biotechnology|November 6, 2023
Generative Artificial Intelligence-Assisted Protein Design Must Consider Repurposing PotentialSean Ekins, Maximilian Brackmann, Cédric Invernizzi, et al.
Pageof 38

Showing results (91-100 of 374) with videos related to

Sort By:
Pageof 38
Journal of Cheminformatics|March 24, 2015
Machines first, humans second: on the importance of algorithmic interpretation of open chemistry dataAlex M Clark, Antony J Williams, Sean Ekins
Drug Discovery Today|July 23, 2023
Learning from COVID-19: How drug hunters can prepare for the next pandemicAna C Puhl, Thomas R Lane, Sean Ekins
Nature Machine Intelligence|October 10, 2022
Dual Use of Artificial Intelligence-powered Drug DiscoveryFabio Urbina, Filippa Lentzos, Cédric Invernizzi, et al.
Trends in Pharmacological Sciences|April 23, 2003
In vitro and pharmacophore insights into CYP3A enzymesSean Ekins, David M Stresser, J Andrew Williams
Plos Neglected Tropical Diseases|October 21, 2016
OpenZika: An IBM World Community Grid Project to Accelerate Zika Virus Drug DiscoverySean Ekins, Alexander L Perryman, Carolina Horta Andrade
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 23, 2015
Making Transporter Models for Drug-Drug Interaction Prediction MobileSean Ekins, Alex M Clark, Stephen H Wright
Journal of Proteome Research|July 25, 2008
Intrinsic disorder in nuclear hormone receptorsMatthew D Krasowski, Erica J Reschly, Sean Ekins
Pharmaceutical Research|November 6, 2020
Correction to: Tilorone: a Broad-Spectrum Antiviral Invented in the USA and Commercialized in Russia and beyondSean Ekins, Thomas R Lane, Peter B Madrid
F1000Research|July 18, 2014
Recommendations to enable drug development for inherited neuropathies: Charcot-Marie-Tooth and Giant Axonal NeuropathyLori Sames, Allison Moore, Renee Arnold, et al.
GEN Biotechnology|November 6, 2023
Generative Artificial Intelligence-Assisted Protein Design Must Consider Repurposing PotentialSean Ekins, Maximilian Brackmann, Cédric Invernizzi, et al.
Pageof 38